SDC
ActiveSummary
SDC has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €266,265 and a net result of €3,372. Equity remains stable across the filed fiscal years (±1.9% per year). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 49 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (2)
History
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Click a name to add, emphasise or remove a line.
Peer companies
Historical observationOf the 17,027 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 94% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,027 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | €348 | €348 | €384 | €387 | €400 | ▲ 3.2% |
| Gross operating margin9900 | -€1,525 | -€1,703 | -€5,327 | -€1,537 | -€2,508 | ▼ 63.1% |
| Operating profit (loss)9901 | -€1,873 | -€2,051 | -€5,711 | -€1,924 | -€2,907 | ▼ 51.1% |
| Financial income75/76B | €2,865 | €4,571 | €10,287 | €11,154 | €7,584 | ▼ 32.0% |
| Recurring financial income75 | €2,865 | €4,571 | €10,287 | €11,154 | €7,584 | ▼ 32.0% |
| Financial charges65/66B | €143 | €150 | €150 | €150 | €180 | ▲ 20.0% |
| Recurring financial charges65 | €143 | €150 | €150 | €150 | €180 | ▲ 20.0% |
| Profit (loss) for the period before taxes9903 | €850 | €2,370 | €4,425 | €9,080 | €4,497 | ▼ 50.5% |
| Income taxes67/77 | €78 | €632 | €1,106 | €2,354 | €1,124 | ▼ 52.3% |
| Profit (loss) for the period9904 | €771 | €1,738 | €3,319 | €6,726 | €3,372 | ▼ 49.9% |
| Profit (loss) for the period to be appropriated9905 | €771 | €1,738 | €3,319 | €6,726 | €3,372 | ▼ 49.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €302,552 | €304,922 | €261,059 | €264,716 | €268,224 | ▲ 1.3% |
| Current assets29/58 | €302,552 | €304,922 | €261,059 | €264,716 | €268,224 | ▲ 1.3% |
| Amounts receivable within one year40/41 | €302,552 | €304,922 | €261,059 | €264,716 | €268,224 | ▲ 1.3% |
| Other amounts receivable41 | €302,552 | €304,922 | €261,059 | €264,716 | €268,224 | ▲ 1.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €302,552 | €304,922 | €261,059 | €264,716 | €268,224 | ▲ 1.3% |
| Equity10/15 | €302,110 | €303,848 | €256,167 | €262,892 | €266,265 | ▲ 1.3% |
| Contributions10/11 | €112,278 | €112,278 | €112,278 | €112,278 | €112,278 | = |
| Reserves13 | €189,832 | €191,570 | €143,889 | €150,614 | €153,987 | ▲ 2.2% |
| Distributable reserves133 | €189,832 | €191,570 | €143,889 | €150,614 | €153,987 | ▲ 2.2% |
| Amounts payable17/49 | €441 | €1,074 | €4,892 | €1,824 | €1,959 | ▲ 7.4% |
| Amounts payable within one year42/48 | €441 | €1,074 | €4,892 | €1,824 | €1,959 | ▲ 7.4% |
| Trade debts44 | €363 | €363 | €4,153 | €363 | €605 | ▲ 66.7% |
| Suppliers440/4 | €363 | €363 | €4,153 | €363 | €605 | ▲ 66.7% |
| Taxes, remuneration and social security45 | €78 | €711 | €739 | €1,461 | €1,354 | ▼ 7.3% |
| Taxes450/3 | €78 | €711 | €739 | €1,461 | €1,354 | ▼ 7.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €771 | €1,738 | €3,319 | €6,726 | €3,372 | ▼ 49.9% |
| Operating cash flow (approximation) | €771 | €1,738 | €3,319 | €6,726 | €3,372 | ▼ 49.9% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
29-07
State Gazette act
Resignation: BV ALEXO (director)Permanent representatives: Olivier Delaere, Koen Straetmans and Tom Goderis · Appointment: BV KST Pharma (director) · Reappointment: BV SODIAP (managing director)6 facts ▸
- Director resignation, BV ALEXO (director)
- Permanent representative, Olivier Delaere (permanent representative)
- Director appointment, BV KST Pharma (director)
- Permanent representative, Koen Straetmans (permanent representative)
- Director reappointment, BV SODIAP (managing director)
- Permanent representative, Tom Goderis (permanent representative)
Show earlier events
About the unread acts
Of the 7 Belgian State Gazette acts we know for this company, 1 has been read. The other 6 have not been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
Board 1
Day-to-day management 1
Permanent representatives 2
Not every act has been read: a resignation may be missing here
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36494D0117/00M002 | Flanders | 3.0 ha | 1 · 1.2 ha | 6.3 m · 2 fl. |
Linked by address, not proof of ownership
Mandate history
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| BV KST Pharma |
|
| BV SODIAP |
|
| BV ALEXO |
|
Structure & network
Owners and holdings
1 ownerChain of control
Highest known parent: PHARMACIE BIA. The sources do not say who stands above it.
Owners 1
- SODIAPparentSourceaccounts SODIAP 2025100%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
Identification & contact
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.